CA2144189A1 - Prevention of stenosis - Google Patents

Prevention of stenosis

Info

Publication number
CA2144189A1
CA2144189A1 CA002144189A CA2144189A CA2144189A1 CA 2144189 A1 CA2144189 A1 CA 2144189A1 CA 002144189 A CA002144189 A CA 002144189A CA 2144189 A CA2144189 A CA 2144189A CA 2144189 A1 CA2144189 A1 CA 2144189A1
Authority
CA
Canada
Prior art keywords
mycophenolate mofetil
pharmaceutically acceptable
acceptable salt
mycophenolic acid
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002144189A
Other languages
English (en)
French (fr)
Inventor
Elizabeth B. Fraser-Smith
Anthony C. Allison
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FI952479A priority Critical patent/FI952479A7/fi
Priority to HU9501067A priority patent/HUT72753A/hu
Priority to PCT/US1992/009932 priority patent/WO1994012184A1/en
Priority to EP93900534A priority patent/EP0670724A1/en
Priority to JP6513067A priority patent/JPH08503487A/ja
Priority to AU31782/93A priority patent/AU3178293A/en
Priority to CA002144189A priority patent/CA2144189A1/en
Priority claimed from PCT/US1992/009932 external-priority patent/WO1994012184A1/en
Publication of CA2144189A1 publication Critical patent/CA2144189A1/en
Priority to NO951966A priority patent/NO951966D0/no
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002144189A 1992-11-24 1992-11-24 Prevention of stenosis Abandoned CA2144189A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FI952479A FI952479A7 (fi) 1992-11-24 1992-11-24 Stenoosin ehkäisy
HU9501067A HUT72753A (en) 1992-11-24 1992-11-24 Pharmaceutical compositions containing mycophenolic acid derivatives for inhibiting stenosis
PCT/US1992/009932 WO1994012184A1 (en) 1992-11-24 1992-11-24 Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
EP93900534A EP0670724A1 (en) 1992-11-24 1992-11-24 Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
JP6513067A JPH08503487A (ja) 1992-11-24 1992-11-24 狭窄症を抑止するためのミコフェノール酸、ミコフェノール酸モフェチルまたはそれらの誘導体の使用
AU31782/93A AU3178293A (en) 1992-11-24 1992-11-24 Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
CA002144189A CA2144189A1 (en) 1992-11-24 1992-11-24 Prevention of stenosis
NO951966A NO951966D0 (enExample) 1992-11-24 1995-05-18

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98083892A 1992-11-24 1992-11-24
PCT/US1992/009932 WO1994012184A1 (en) 1992-11-24 1992-11-24 Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
CA002144189A CA2144189A1 (en) 1992-11-24 1992-11-24 Prevention of stenosis

Publications (1)

Publication Number Publication Date
CA2144189A1 true CA2144189A1 (en) 1994-06-09

Family

ID=27169974

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002144189A Abandoned CA2144189A1 (en) 1992-11-24 1992-11-24 Prevention of stenosis

Country Status (2)

Country Link
CA (1) CA2144189A1 (enExample)
NO (1) NO951966D0 (enExample)

Also Published As

Publication number Publication date
NO951966L (enExample) 1995-05-18
NO951966D0 (enExample) 1995-05-18

Similar Documents

Publication Publication Date Title
WO1994012184A1 (en) Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
US5922757A (en) Treatment and prevention of hepatic disorders
JP6846392B2 (ja) 選択的ｓ１ｐ１レセプターアゴニストを含む薬学的合剤
KR20010015807A (ko) 9-데옥시-2',9-알파-메타노-3-옥사-4,5,6-트리노르-3,7-(1',3'-인터페닐렌)-13,14-디하이드로-프로스타글란딘에프1을 이용한 말초 혈관 질환의 치료
KR101823451B1 (ko) 퀴논계 화합물, 이의 광학 이성질체 및 이의 제조 방법과 의약 용도
AU5030399A (en) Agents with an antidepressive effect
HU190699B (en) Process for producing analgesic composition containing nalbufin
JPH06234635A (ja) インターロイキン１ベータを阻害するためのレフルノミドの使用
EP0682947B1 (en) Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia
JP2000503298A (ja) メデトミジン誘導体のレボエナンチオマーの医薬組成物および使用
EP2994461B1 (en) Methods of treating skin conditions using cyclolignan compounds
CA2144189A1 (en) Prevention of stenosis
CA1255593A (en) Antiinflammatory compositions and methods
EP0664127B1 (en) Pharmaceutical compositions containing isoquinoline derivatives
NZ189159A (en) Oral antihypertensive compositions containing proline derivatives
EP0650723A2 (en) Novel pharmaceutical use of forskolin derivatives
WO2005007191A1 (ja) 医薬組成物
AU3178293A (en) Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
ES2378374T3 (es) Inhibidores de la PDE 4 para el tratamiento de la cistitis intersticial
US5981538A (en) Methods of treating psoriasis employing substituted azaspiranes
US5340805A (en) Danazol for treatment of urinary incontinence
JP2657614B2 (ja) アロマターゼ阻害剤
JPH10511673A (ja) スクラレオリドを用いる細胞過度増殖を特徴とする病気の処置法
CZ211897A3 (en) Use of 3,4-diphenylchromans for preparing pharmaceutical preparations used for dilation of vessels
Gelfman et al. Unresectable pheochromocytoma: Response to α-methyl-dihydroxy-l-phenylalanine

Legal Events

Date Code Title Description
FZDE Discontinued